GlassScriptPhysician profile
Venkat Seshadri
NPI 1093918203
$16,429.90
in general payments reported to CMS, 2019-2025
25 companies · $2,192 in 2025
The $2,192 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,498 · 2020: $1,536 · 2021: $2,786 · 2022: $3,079 · 2023: $759 · 2024: $1,580 · 2025: $2,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,539 · Food and Beverage: $1,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,538.78 |
| Food and Beverage | $1,991.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $4,953.05 | 2019-2023 | |
| Arthrex, INC. | $4,949.96 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,251.39 | 2021-2024 | Attune |
| Lightbody Medical Technologies INC | $1,226.52 | 2024-2025 | |
| Encore Medical, LP | $1,189.18 | 2019 | |
| Depuy Synthes Sales INC. | $957.34 | 2019-2024 | Attune, Velys, Inhance |
| Wright Medical Technology, INC. | $643.90 | 2019 | |
| Endo Pharmaceuticals INC. | $249.86 | 2019-2023 | Xiaflex |
| Smith+Nephew, INC. | $157.91 | 2022 | |
| Stryker Corporation | $148.53 | 2023 | T2, Gamma |
| Boston Scientific Corporation | $131.52 | 2020-2023 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Seapearl East, INC | $109.88 | 2021 | |
| Catalyst Orthoscience | $61.34 | 2024 | Catalyst Csr Shoulder System |
| Orthofix Medical, INC. | $48.02 | 2020-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $42.41 | 2023 | Innate Implant, Acumed |
| Almatica Pharma LLC | $30.39 | 2022 | |
| Amgen INC. | $28.40 | 2024 | Krystexxa |
| Nevro Corp. | $27.30 | 2020 | |
| Sanara Medtech INC. | $22.18 | 2025 | Celleraterx |
| Horizon Therapeutics Plc | $20.38 | 2019 | |
| Zyla Life Sciences, INC. | $15.30 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.17 | 2019 | |
| Axogen | $13.03 | 2019 | |
| Electronic Waveform Lab, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkat Seshadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.